Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.05B |
| 2 |
Texas Instruments
TXN
|
+$1.69B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Starbucks
SBUX
|
+$1.2B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$949M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.77B |
| 2 |
Microsoft
MSFT
|
+$1.3B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.22B |
| 4 |
iShares US Real Estate ETF
IYR
|
+$1.11B |
| 5 |
Procter & Gamble
PG
|
+$915M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.33% |
| 2 | Consumer Discretionary | 7.25% |
| 3 | Financials | 7.18% |
| 4 | Communication Services | 6.16% |
| 5 | Healthcare | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3651
Phathom Pharmaceuticals
PHAT
$692M
| $128K | ﹤0.01% |
12,405
-15,794
| -56% | -$163K |
|
3652
Advantage Solutions
ADV
$361M
| $128K | ﹤0.01% |
1,586
-1,756
| -53% | -$163K |
|
3653
OmniAb
OABI
$447M
| $127K | ﹤0.01% |
33,979
-48,946
| -59% | -$223K |
|
|
MCBC
3654
DELISTED
Macatawa Bank Corp
MCBC
| $127K | ﹤0.01% |
8,689
-47,284
| -84% | -$631K |
|
|
ALIM
3655
DELISTED
Alimera Sciences
ALIM
| $127K | ﹤0.01% |
+22,791
| New | +$80.9K |
|
3656
Westrock Coffee
WEST
$803M
| $126K | ﹤0.01% |
12,364
-13,955
| -53% | -$143K |
|
3657
Carter Bankshares
CARE
$731M
| $126K | ﹤0.01% |
8,356
-7,189
| -46% | -$89.9K |
|
3658
State Street SPDR S&P China ETF
GXC
$482M
| $126K | ﹤0.01% |
1,844
| – | – |
|
3659
Granite Ridge Resources
GRNT
$644M
| $126K | ﹤0.01% |
19,930
-16,859
| -46% | -$109K |
|
3660
Greenlight Captial
GLRE
$506M
| $126K | ﹤0.01% |
9,609
-8,439
| -47% | -$108K |
|
|
CWBC
3661
Community West Bancshares
CWBC
$684M
| $124K | ﹤0.01% |
6,714
-207
| -3% | -$3.63K |
|
3662
Brookfield Renewable
BEP
$9.96B
| $124K | ﹤0.01% |
5,011
-4,101
| -45% | -$102K |
|
3663
Excelerate Energy
EE
$1.11B
| $124K | ﹤0.01% |
6,709
-9,945
| -60% | -$171K |
|
3664
NVE Corp
NVEC
$609M
| $123K | ﹤0.01% |
1,646
-1,713
| -51% | -$134K |
|
3665
Greif Class B
GEF.B
$4.21B
| $123K | ﹤0.01% |
1,964
-2,535
| -56% | -$164K |
|
|
CNSL
3666
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $123K | ﹤0.01% |
27,858
-39,976
| -59% | -$173K |
|
3667
Everspin Technologies
MRAM
$405M
| $122K | ﹤0.01% |
20,414
-14,626
| -42% | -$96.8K |
|
|
ACRE
3668
Ares Commercial Real Estate
ACRE
$270M
| $122K | ﹤0.01% |
18,386
-28,045
| -60% | -$194K |
|
3669
Limoneira
LMNR
$251M
| $122K | ﹤0.01% |
5,872
-6,426
| -52% | -$129K |
|
3670
Rayonier Advanced Materials
RYAM
$610M
| $122K | ﹤0.01% |
22,456
-26,058
| -54% | -$127K |
|
|
TBCH
3671
Turtle Beach Corp
TBCH
$277M
| $122K | ﹤0.01% |
8,497
-15,891
| -65% | -$247K |
|
3672
State Street SPDR S&P Aerospace & Defense ETF
XAR
$6.49B
| $122K | ﹤0.01% |
870
| – | – |
|
3673
Riskified
RSKD
$716M
| $121K | ﹤0.01% |
18,961
-11,786
| -38% | -$66.7K |
|
3674
Radware
RDWR
$1.19B
| $121K | ﹤0.01% |
6,631
-8,072
| -55% | -$147K |
|
3675
Black Diamond Therapeutics
BDTX
$112M
| $121K | ﹤0.01% |
25,886
-141,360
| -85% | -$759K |
|
Similar funds
Barclays's Q2 2024 Portfolio in Review
As of Q2 2024, Barclays held 5,455 positions worth $327B, up 14% from $288B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Barclays deployed $29.4B of net new capital in Q2 2024, opening 406 new positions and adding to 1,053 existing holdings. Its largest new stake was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Apple, an estimated $2.77B trimmed.
- Barclays's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
- Barclays added most to CRH in Q2 2024, an estimated $2.05B increase.
- Barclays's biggest Q2 2024 reduction was Apple, cutting an estimated $2.77B.
- Barclays fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $212M.
- Barclays's ten largest holdings make up 42% of its $327B portfolio in Q2 2024.
- Barclays opened 406 new positions and closed 646 in Q2 2024.
- Barclays's portfolio value rose 14% quarter-over-quarter to $327B.
Based on Barclays's 13F filing for Q2 2024, filed 14 Aug 2024.